Patents by Inventor Hugh Willison

Hugh Willison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment of antibody mediated neuropathies
    Patent number: 9388235
    Abstract: The use of a therapeutic capable of inhibiting complement, e.g., an anti-C5 antibody, to treat antibody mediated neuropathies is disclosed.
    Type: Grant
    Filed: September 5, 2007
    Date of Patent: July 12, 2016
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Susan Halstead, Hugh Willison, Russell P. Rother
  • Detection of Interactions Between Lipid Complexes and Lipid Binding Agents
    Publication number: 20110172106
    Abstract: The invention relates to materials and methods for detecting interactions between lipid complexes and lipid binding agents. More specifically, the invention provides materials and methods for displaying lipid complexes, particularly those containing two or more different lipid molecules, on a hydrophobic surface so as to mimic their in vivo environment more closely than in other analytical methods. This allows more accurate detection of lipid complexes and even identification of lipid complexes which are not detected by other methods. The invention lends itself particularly well to array or microarray formats.
    Type: Application
    Filed: July 3, 2009
    Publication date: July 14, 2011
    Applicant: THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
    Inventors: Hugh Willison, Carl Goodyear, Kathryn Brennan, Simon Rinaldi
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF ANTIBODY MEDIATED NEUROPATHIES
    Publication number: 20100143343
    Abstract: The use of a therapeutic capable of inhibiting complement, e.g., an anti-C5 antibody, to treat antibody mediated neuropathies is disclosed.
    Type: Application
    Filed: September 5, 2007
    Publication date: June 10, 2010
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Susan Halstead, Hugh Willison, Russell P. Rother